8-Azahypoxanthine
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 591235

CAS#: 2683-90-1

Description: 8-Azahypoxanthine is an antimalarial that inhibits hypoxanthine-guanine-xanthine phosphoribosyltransferase.


Chemical Structure

img
8-Azahypoxanthine
CAS# 2683-90-1

Theoretical Analysis

MedKoo Cat#: 591235
Name: 8-Azahypoxanthine
CAS#: 2683-90-1
Chemical Formula: C4H5N5O
Exact Mass: 139.0494
Molecular Weight: 139.12
Elemental Analysis: C, 34.53; H, 3.62; N, 50.34; O, 11.50

Price and Availability

Size Price Availability Quantity
1.0g USD 440.0 2 Weeks
Bulk inquiry

Synonym: 8-Azahypoxanthine; NSC 22709; NSC-22709; NSC22709;

IUPAC/Chemical Name: 4,5-Dihydro-1H-triazolo(4,5-d)pyrimidin-4-ol

InChi Key: CKNDSAMZNSQIHY-UHFFFAOYSA-N

InChi Code: InChI=1S/C4H5N5O/c10-9-2-5-1-3-4(9)7-8-6-3/h1,10H,2H2,(H,6,7,8)

SMILES Code: ON1CN=CC2=C1N=NN2

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 139.12 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Groom J, Chung D, Olson DG, Lynd LR, Guss AM, Westpheling J. Promiscuous plasmid replication in thermophiles: Use of a novel hyperthermophilic replicon for genetic manipulation of Clostridium thermocellum at its optimum growth temperature. Metab Eng Commun. 2016 Jan 29;3:30-38. doi: 10.1016/j.meteno.2016.01.004. eCollection 2016 Dec. PubMed PMID: 29468112; PubMed Central PMCID: PMC5779722.

2: Keough DT, Skinner-Adams T, Jones MK, Ng AL, Brereton IM, Guddat LW, de Jersey J. Lead compounds for antimalarial chemotherapy: purine base analogs discriminate between human and P. falciparum 6-oxopurine phosphoribosyltransferases. J Med Chem. 2006 Dec 14;49(25):7479-86. PubMed PMID: 17149876.

3: Moore BC, Leigh JA. Markerless mutagenesis in Methanococcus maripaludis demonstrates roles for alanine dehydrogenase, alanine racemase, and alanine permease. J Bacteriol. 2005 Feb;187(3):972-9. PubMed PMID: 15659675; PubMed Central PMCID: PMC545699.

4: Bohne W, Roos DS. Stage-specific expression of a selectable marker in Toxoplasma gondii permits selective inhibition of either tachyzoites or bradyzoites. Mol Biochem Parasitol. 1997 Sep;88(1-2):115-26. PubMed PMID: 9274873.

5: Balo C, Fernández F, Lens E, López C, Andrei G, Snoeck R, Balzarini J, De CLercq E. Novel carbocyclic nucleosides containing a cyclopentyl ring. Adenosine and uridine analogues. Arch Pharm (Weinheim). 1997 Aug;330(8):265-7. PubMed PMID: 9361523.

6: Bowen TL, Lin WC, Whitman WB. Characterization of guanine and hypoxanthine phosphoribosyltransferases in Methanococcus voltae. J Bacteriol. 1996 May;178(9):2521-6. PubMed PMID: 8626317; PubMed Central PMCID: PMC177974.

7: Szybalski W. Use of the HPRT gene and the HAT selection technique in DNA-mediated transformation of mammalian cells: first steps toward developing hybridoma techniques and gene therapy. Bioessays. 1992 Jul;14(7):495-500. PubMed PMID: 1445289.

8: Ladapo J, Whitman WB. Method for isolation of auxotrophs in the methanogenic archaebacteria: role of the acetyl-CoA pathway of autotrophic CO2 fixation in Methanococcus maripaludis. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5598-602. PubMed PMID: 11607093; PubMed Central PMCID: PMC54374.

9: Biagi G, Giorgi I, Livi O, Scartoni V, Lucacchini A. Xanthine oxidase inhibition: effect of an N-alkyl substituent on C-2 of the nucleus of 8-azahypoxanthine. Farmaco. 1989 Sep;44(9):843-9. PubMed PMID: 2604836.

10: Bowen TL, Whitman WB. Incorporation of Exogenous Purines and Pyrimidines by Methanococcus voltae and Isolation of Analog-Resistant Mutants. Appl Environ Microbiol. 1987 Aug;53(8):1822-6. PubMed PMID: 16347408; PubMed Central PMCID: PMC204007.

11: Schimandle CM, Mole LA, Sherman IW. Purification of hypoxanthine-guanine phosphoribosyltransferase of Plasmodium lophurae. Mol Biochem Parasitol. 1987 Feb;23(1):39-45. PubMed PMID: 3574349.

12: Takimoto T, Ogura H, Ohno S, Umeda R, Hatano M. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line. J Natl Cancer Inst. 1984 Sep;73(3):711-5. PubMed PMID: 6088881.

13: Takimoto T, Furukawa M, Hatano M, Umeda R. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells. Ann Otol Rhinol Laryngol. 1984 Mar-Apr;93(2 Pt 1):166-9. PubMed PMID: 6324641.

14: Volchkov VA, Mikhaĭlova NIa. [Radiomodifying action of 8-azahypoxanthine]. Radiobiologiia. 1984 Jan-Feb;24(1):90-2. Russian. PubMed PMID: 6709851.

15: Bakay B, Nissinen E, Sweetman L, Francke U, Nyhan WL. Utilization of purines by an HPRT variant in an intelligent, nonmutilative patient with features of the Lesch-Nyhan syndrome. Pediatr Res. 1979 Dec;13(12):1365-70. PubMed PMID: 523196.

16: Bose SN, Davies RJ, Boyd DR. The mass spectra of 8-azapurines. Biomed Mass Spectrom. 1977 Oct;4(5):305-9. PubMed PMID: 912032.

17: Szepesi B. Effect of aza-substituted nucleotides on the starve-refeed response of rats. Proc Soc Exp Biol Med. 1975 Mar;148(3):615-9. PubMed PMID: 48259.

18: Vaughan MH, Steele MW. Differential sensitivity of human normal and malignant cells to 8-azahypoxanthine in vitro. Exp Cell Res. 1971 Nov;69(1):92-6. PubMed PMID: 5166378.

19: Silagi S, Darlington G, Bruce SA. Hybridization of two biochemically marked human cell lines. Proc Natl Acad Sci U S A. 1969 Apr;62(4):1085-92. PubMed PMID: 5256409; PubMed Central PMCID: PMC223618.

20: FREDERIKSEN S. DEOXYRIBOSYL-8-AZAADENINE. ITS DEAMINATION TO DEOXYRIBOSYL-8-AZAHYPOXANTHINE AND EFFECT ON NUCLEIC ACID SYNTHESIS IN EHRLICH ASCITES CELLS IN VITRO. Biochim Biophys Acta. 1964 Aug 12;87:574-82. PubMed PMID: 14220687.